Reduced-intensity haploidentical peripheral blood stem cell transplantation using low-dose thymoglobulin for aggressive adult T cell leukemia/lymphoma patients in non-complete remission

Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) has been accepted as a treatment option for aggressive (acute or lymphoma type) adult T cell leukemia/lymphoma (ATLL) patients with a poor prognosis, when a suitable HLA-matched donor is not available. However, haplo-HSCT carries a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Hematol
Hlavní autoři: Hirosawa, Makoto, Yamaguchi, Takahiro, Tanaka, Aya, Kominato, Yoshihiko, Higashi, Takehiro, Morimoto, Hiroaki, Tsukada, Junichi
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Berlin Heidelberg 2020
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7060159/
https://ncbi.nlm.nih.gov/pubmed/32006150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-020-03934-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky